Evidence mapPaperPMID 38610938Full record

ArticleCancers2024

Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer.

Leila Shobab, Hui Zheng, Kirk Jensen, Maria Cecilia Mendonca-Torres, Matthew McCoy, Victoria Hoperia, Jennifer Rosen, Leonard Wartofsky, Kenneth Burman, Vasyl Vasko

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Leila ShobabDepartment of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Hui ZhengDepartment of Surgery, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Kirk JensenDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.ORCID 0000-0002-4213-5371
Maria Cecilia Mendonca-TorresDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Matthew McCoyInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0001-7601-6963
Victoria HoperiaInstitute of Biology and Medicine, Kyiv National University, 02000 Kyiv, Ukraine.
Jennifer RosenDepartment of Surgery, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Leonard WartofskyDepartment of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.ORCID 0000-0002-2183-6929
Kenneth BurmanDepartment of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Vasyl VaskoDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.ORCID 0000-0003-1404-8446
MedStar Washington Hospital Center · USUniformed Services University of the Health Sciences · USGeorgetown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of thyroid cancer in women is 3-4-fold higher than in men. To characterize sex-specific molecular alterations in thyroid cancer, we examined the expression of sex-biased genes in normal thyroids and thyroid tumors.

methodsIngenuity pathways analysis was used to define sex-biased gene networks using data from the Cancer Genome Atlas (TCGA). Confirmatory studies were performed through the analysis of histone lysine demethylases (KDMs) expression by real-time PCR and immunostaining.

resultsIn normal thyroids, 44 sex-biased genes were comparatively upregulated in male and 28 in female patients. The expressions of 37/72 (51%) sex-biased genes were affected in cancer tissues compared with normal thyroids. Gene network analyses revealed sex-specific patterns in the expressions of KDM5C, KDM5D, and KDM6A. In confirmatory studies, KDM5D mRNA and protein were detected only in males, whereas KDM5C and KDM6A were detected in samples from male and female patients. Nuclear staining with anti-KDMs was found in normal thyroids, but a loss of nuclear expression with a concomitant gain of cytoplasmic staining was observed in cancer tissues.

conclusionsNormal thyroids have a sex-specific molecular signature, and the development of thyroid cancer is associated with a differential expression of sex-biased genes. The sex-specific expression of KDMs, coupled with cancer-related alterations in their intracellular localization, may contribute to mechanisms underlying sex differences in thyroid tumorigenesis.

Indexed as

histone lysine demethylasesKDMssex differencethyroid cancer

Identifiers

PMID38610938
PMCPMC11010840
OpenAlexW4393142650

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.